RETIVU Trademark

Trademark Overview

On Tuesday, December 20, 2022, a trademark application was filed for RETIVU with the United States Patent and Trademark Office. The USPTO has given the RETIVU trademark a serial number of 97724847. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, October 2, 2025. This trademark is owned by EyePoint Pharmaceuticals US, Inc.. The RETIVU trademark is filed in the Pharmaceutical Products category with the following description:

Injectable pharmaceutical preparations for use by ophthalmologists, or other medical professionals qualified to administer ocular injections, for the treatment of eye diseases and conditions, excluding the treatment of cancer
retivu

General Information

Serial Number97724847
Word MarkRETIVU
Filing DateTuesday, December 20, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, October 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements

Goods and ServicesInjectable pharmaceutical preparations for use by ophthalmologists, or other medical professionals qualified to administer ocular injections, for the treatment of eye diseases and conditions, excluding the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, January 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEyePoint Pharmaceuticals US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472
Party NameEyePoint Pharmaceuticals US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472

Trademark Events

Event DateEvent Description
Friday, September 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 23, 2022NEW APPLICATION ENTERED
Tuesday, January 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 21, 2023ASSIGNED TO EXAMINER
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, November 30, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Wednesday, February 14, 2024TEAS POST PUBLICATION AMENDMENT RECEIVED
Sunday, March 10, 2024EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Monday, March 18, 2024ASSIGNED TO PETITION STAFF
Wednesday, March 20, 2024POST PUBLICATION AMENDMENT - ENTERED
Tuesday, April 30, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, June 10, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 10, 2024SOU EXTENSION 1 FILED
Monday, June 10, 2024SOU EXTENSION 1 GRANTED
Monday, December 2, 2024REINSTATEMENT GRANTED - INADVERTENTLY ABANDONED
Wednesday, March 26, 2025SOU TEAS EXTENSION RECEIVED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 2, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, December 2, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Wednesday, March 26, 2025SOU EXTENSION 2 FILED
Thursday, March 27, 2025SOU EXTENSION 2 GRANTED
Thursday, October 2, 2025SOU EXTENSION 3 FILED
Thursday, October 2, 2025SOU TEAS EXTENSION RECEIVED
Thursday, October 2, 2025SOU EXTENSION 3 GRANTED
Thursday, October 2, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 27, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

retivu treatment injections ocular diseases conditions cancer excluding administer qualified preparations